Dow Down 1.29% Nasdaq Down 3.25%

More On ABBV.PA

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

AbbVie Inc. (ABBV.PA)

-Paris
49.90 Up 1.04(2.13%) Feb 2, 11:20AM EST
Prev Close:49.90
Open:49.90
Bid:47.21 x 1000
Ask:48.94 x 1300
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:49.90 - 49.90
52wk Range:46.49 - 65.55
Volume:30
Avg Vol (3m):45
Market Cap:81.57B
P/E (ttm):15.94
EPS (ttm):3.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback